| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | 1 | — | 4 | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 2.72 |
—
—
—
|
| 2025 | 2.68 |
—
—
—
—
|
| 2024 | 2.64 |
—
—
—
—
|
| 2023 | 2.60 |
—
—
—
—
|
| 2022 | 2.56 |
—
—
—
—
|
| 2021 | 3.15 |
—
—
—
—
—
|
| 2020 | 2.48 |
—
—
—
—
|
| 2019 | 2.44 |
—
—
—
—
|
| 2018 | 2.40 |
—
—
—
—
|
| 2017 | 2.32 |
—
—
—
—
|
| 2016 | 2.20 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 367.80 | 287.80 | 138.00 | 302.10 |
| Receivables | 315.40 | 207.40 | 239.50 | 314.20 |
| Inventory | 1,810.50 | 1,741.50 | 1,412.40 | 1,566.00 |
| Other | — | — | 49.80 | 25.00 |
| 2,691.70 | 2,632.40 | 2,206.60 | 2,567.70 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 713.10 | 562.80 | 762.50 | 883.00 |
| ST’ Debt | 54.00 | — | — | — |
| Other | 43.10 | 36.40 | 91.00 | 37.60 |
| 1,933.80 | 2,293.20 | 2,243.30 | 2,140.50 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1,658.70 | 2,022.80 | — | — |
—
|
| ’25 | 1,535.80 | 1,852.70 | 1,841.60 | 1,921.90 |
7,152.00
|
| ’24 | 1,736.40 | 1,961.20 | 1,722.40 | 1,755.40 |
7,175.40
|
| ’23 | 2,179.70 | 2,216.60 | 2,248.90 | 2,289.20 |
8,934.40
|
| ’22 | 1,781.50 | 2,062.80 | 2,340.60 | 2,404.10 |
8,589.00
|
| ’21 | 1,951.10 | 1,911.10 | 1,777.70 | 1,799.30 |
7,439.20
|
| ’20 | 1,405.20 | 1,511.80 | 1,954.60 | 1,409.80 |
6,281.40
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (320.20) | 230.20 | — | — |
—
|
| ’25 | 83.20 | 320.30 | 158.80 | 178.70 |
741.00
|
| ’24 | (105.40) | 146.30 | 21.00 | 206.30 |
268.20
|
| ’23 | 124.20 | 223.70 | 28.10 | 549.80 |
925.80
|
| ’22 | (49.10) | (7.90) | 170.60 | 395.00 |
508.60
|
| ’21 | 56.00 | 139.60 | (42.20) | 140.30 |
293.70
|
| ’20 | (71.40) | 381.10 | 366.00 | 342.90 |
1,018.60
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (349.90) | 186.10 | — | — |
—
|
| ’25 | 47.60 | 279.80 | 116.70 | 114.00 |
558.10
|
| ’24 | (177.50) | 79.10 | (32.40) | 137.30 |
6.50
|
| ’23 | 29.80 | 111.90 | (77.40) | 448.90 |
513.20
|
| ’22 | (104.90) | (71.50) | 96.40 | 282.00 |
202.00
|
| ’21 | 10.60 | 75.90 | (122.30) | 46.70 |
10.90
|
| ’20 | (118.20) | 339.80 | 322.30 | 270.40 |
814.30
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.83) | 1.82 | — | — |
—
|
| ’25 | (1.17) | (1.39) | (0.28) | (5.34) |
(8.18)
|
| ’24 | 0.07 | 1.21 | 0.49 | 0.19 |
1.95
|
| ’23 | 1.95 | 2.32 | 2.62 | 1.81 |
8.71
|
| ’22 | 1.14 | (0.08) | 3.10 | 3.34 |
7.44
|
| ’21 | 2.11 | 2.52 | 1.84 | 1.40 |
7.88
|
| ’20 | (0.09) | (3.82) | 2.66 | 3.15 |
1.99
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 91.86 | 82.00 | 55.55 | 30.92 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 127.37 | 138.49 | 100.91 | 75.25 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16,200 | 18,500 | 15,000 | 14,500 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.53 | 0.48 | 0.48 | 0.49 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8,589.00 | 8,934.40 | 7,175.40 | 7,152.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.81% | 21.94% | 20.44% | 19.14% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 761.40 | 620.40 | 140.80 | (532.70) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.86% | 6.94% | 1.96% | (7.45%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 447.60 | 502.70 | 111.20 | (464.80) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 232.80 | 258.90 | 286.30 | 286.50 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 144.84 | 156.47 | 127.00 | 125.69 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 7.54 | 8.80 | 1.96 | (8.18) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.58 | 16.21 | 4.75 | 13.02 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (5.17) | (7.23) | (4.63) | (3.21) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.41 | 8.99 | 0.12 | 9.81 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.58 | 24.88 | 22.90 | 14.64 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 59.30 | 57.10 | 56.50 | 56.90 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.21 | 10.71 | 29.40 | 0.00 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.69 | 0.60 | 0.45 | 0.50 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.41 | 3.79 | 2.52 | 4.32 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.90 | 0.78 | 0.65 | 0.70 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 38.08 | 13.50 | 716.90 | 8.99 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 508.60 | 925.80 | 268.20 | 741.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (306.60) | (412.60) | (261.70) | (182.90) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 202.00 | 513.20 | 6.50 | 558.10 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 439.00 | 757.90 | 339.20 | (36.70) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,057.80 | 1,908.40 | 1,638.10 | 1,504.70 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,733.30 | 1,540.60 | 1,350.30 | 1,366.70 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,101.50 | 1,420.80 | 1,294.10 | 832.90 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.71% | 9.37% | 2.01% | (8.94%) | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.74% | 14.79% | 6.87% | (9.91%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 38.41% | 39.87% | 8.16% | (43.77%) | — | — | — |
ROE
|
Polaris Inc. (PII), the off-road and powersports powerhouse, is reeling from a post-pandemic spending slump, with revenue plunging 20% to $7.18 billion in 2024 after peaking at $8.93 billion in 2023. High dealer inventories, softening demand, and eroding gross margins (down to 20.4%) have hammered profitability, projecting a $465 million net loss and negative ROE of -72% for 2025. Yet, the stock trades at dirt-cheap valuations—PS ratio at 0.45x, PB below 3x—languishing near $66, just 4% below the mean analyst target but 38% above the bear case, screaming potential undervaluation for contrarians eyeing a gritty rebound.
Balance sheet strains like negative working capital and stable $1.35 billion net debt add caution, while insider selling ($4.2 million in 2025-2026, no buys) signals skepticism amid margin woes. Analysts forecast stabilization—flat revenue in 2025, modest growth to $7.58 billion by 2027, EPS rebounding to $2.99—with FCF recovery potentially fueling buybacks. But risks from high rates, EV lags, and competition loom large.
Is PII a battered cyclical poised for 50%+ historical post-trough gains, or a value trap with deepening losses? Dive into the full analysis for the fundamentals, forecasts, and contrarian thesis that challenges the timid consensus.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.